Ludhmila Abrahão Hajjar

TL;DR: In this article , the authors search Embase, BioMed Central, medRxiv, bioRxivas, PubMed, and the Cochrane Central Register of Controlled Trials for any randomized trial or matched study ever performed on adult patients with severe and critical coronavirus disease 2019 (Covid-19) not receiving oxygen therapy treated with intravenous or oral glucocorticoids versus any comparator (standard therapy or placebo); there were no restrictions on dose or time of administration.

TL;DR: In this article , the authors investigated whether physical capacity increase in patients with heart failure with reduced ejection fraction (HFrEF) is associated with muscle sympathetic nerve activity reduction and muscle blood flow (MBF) increase.

TL;DR: Erdheim-Chester disease is multisystemic, affecting the bones, skin, ocular tissue, lungs, brain, pituitary gland, and other tissues.

TL;DR: In this paper, the authors found that patients with COVID-19 and high risk features have an elevated rate of in-hospital mortality with differences according to age and sex, while older men presented higher rates of death than women (57.6% vs 49.2%).

TL;DR: In the six months CECCY trial analyses, use of carvedilol resulted in a significant reduction in troponin levels and diastolic dysfunction (DD), without difference in LVEF.